Literature DB >> 3403417

Relationship of muscular fatigue to pH and diprotonated Pi in humans: a 31P-NMR study.

J R Wilson1, K K McCully, D M Mancini, B Boden, B Chance.   

Abstract

Seventeen normal subjects performed maximal wrist flexion exercise with continuous monitoring of forearm muscle pH and H2PO4-, measured with 31P nuclear magnetic resonance, and muscle fatigue, expressed as a percentage of decline in maximal developed force. Four minutes of exercise (flexion duration = 1 s) reduced maximal developed force from 100 to 74 +/- 9% and pH from 6.99 +/- 0.04 to 6.17 +/- 0.33 and increased H2PO4- to 927 +/- 401% of resting levels. In all subjects, linear relationships were noted between developed force and pH (r = 0.90 +/- 0.08) and between developed force and H2PO4- (r = -0.89 +/- 0.08). Doubling the contraction duration to 2 s produced more rapid changes in developed force, pH, and H2PO4- but no change in the relationship of force to pH and H2PO4-. Two minutes of submaximal exercise before maximal exercise significantly reduced pH and increased H2PO4-. During subsequent maximal exercise, the relationship between developed force and H2PO4- remained unchanged. In contrast, the relationship between developed force and pH was shifted leftward; muscle pH remained lower throughout maximal exercise, and developed force remained comparable to that noted during control exercise. These observations suggest that muscle fatigue during intense short-term exercise is primarily caused by an increase in intramuscular H2PO4- rather than by a decrease in intramuscular pH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403417     DOI: 10.1152/jappl.1988.64.6.2333

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  37 in total

1.  Relaxation and force during fatigue and recovery of the human quadriceps muscle: relations to metabolite changes.

Authors:  M Bergström; E Hultman
Journal:  Pflugers Arch       Date:  1991-03       Impact factor: 3.657

Review 2.  Metabolic factors in fatigue.

Authors:  K Sahlin
Journal:  Sports Med       Date:  1992-02       Impact factor: 11.136

3.  Combined inhibitory actions of acidosis and phosphate on maximum force production in rat skinned cardiac muscle.

Authors:  J C Kentish
Journal:  Pflugers Arch       Date:  1991-10       Impact factor: 3.657

Review 4.  The measurement of maximal (anaerobic) power output on a cycle ergometer: a critical review.

Authors:  Tarak Driss; Henry Vandewalle
Journal:  Biomed Res Int       Date:  2013-08-29       Impact factor: 3.411

5.  Continuous intramuscular pH measurement during the recovery from brief, maximal exercise in man.

Authors:  P Allsop; M Cheetham; S Brooks; G M Hall; C Williams
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

6.  Influence of exercise variation on the retention of a pacing strategy.

Authors:  Alexis R Mauger; Andrew M Jones; Craig Anthony Williams
Journal:  Eur J Appl Physiol       Date:  2009-12-11       Impact factor: 3.078

7.  Knee extension dynamometer: a new device for dynamic isokinetic magnetic resonance spectroscopy experiments.

Authors:  K T Mattila; M Komu; R Karsikas; P Hatakka; O J Heinonen; M Kormano
Journal:  MAGMA       Date:  1996-06       Impact factor: 2.310

8.  Acidosis affects muscle contraction by slowing the rates myosin attaches to and detaches from actin.

Authors:  Katelyn Jarvis; Mike Woodward; Edward P Debold; Sam Walcott
Journal:  J Muscle Res Cell Motil       Date:  2018-10-31       Impact factor: 2.698

9.  Fatigue and recovery of phosphorus metabolites and pH during stimulation of rat skeletal muscle: an evoked electromyography and in vivo 31P-nuclear magnetic resonance spectroscopy study.

Authors:  T Mizuno; Y Takanashi; K Yoshizaki; M Kondo
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

10.  Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure.

Authors:  C H Thompson; R J Davies; G J Kemp; D J Taylor; G K Radda; B Rajagopalan
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.